Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome.
Saved in:
| Title: | Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome. |
|---|---|
| Authors: | Fraser GL, Obermayer-Pietsch B; Medical University, 8036 Graz,Austria., Laven J; Erasmus MC, 3015 Rotterdam, the Netherlands., Griesinger G; Schleswig-Holstein University Hospital, 23562 Lübeck,Germany., Pintiaux A; CHR Liège Citadelle Hospital, 4020 Liège,Belgium., Timmerman D; University Hospital, KU Leuven, 3000 Leuven, Belgium., Fauser BCJM; University Medical Center, 3584 Utrecht, the Netherlands., Lademacher C; Astellas Pharma US Inc, Northbrook, IL 60062,USA., Combalbert J, Hoveyda HR, Ramael S |
| Source: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2021 Aug 18; Vol. 106 (9), pp. e3519-e3532. |
| Publication Type: | Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1945-7197 |
|---|---|
| DOI: | 10.1210/clinem/dgab320 |
